Skip to main content
Top
Published in: Annals of Hematology 9/2010

01-09-2010 | Original Article

Complex interaction of Hb Q-Thailand and Hb E with α0-thalassemia and hereditary persistence of fetal hemoglobin in a Chinese family

Authors: Weidong Zheng, Yanhui Liu, Dong Chen, Kabin Rong, Yanfen Ge, Caiping Gong, Heping Chen

Published in: Annals of Hematology | Issue 9/2010

Login to get access

Abstract

Hemoglobin (Hb) Q-Thailand, Hb E, and other forms of thalassemia are prevalent in Southeast Asia including China. We report a hitherto undescribed condition in which four forms of Hb defects co-segregate. The proband was a 20-year-old Chinese man who presented with moderate hypochromic microcytosis with Hb 73 g/l, hematocrit (Hct) 27.0%, mean corpuscular volume 57.6 fl, mean corpuscular hemoglobin 15.5 pg, and mean corpuscular hemoglobin concentration (MCHC) 268.0 g/l. Both Hb electrophoresis and high-performance liquid chromatography analysis revealed abnormal Hbs. DNA analysis demonstrated that the proband was a double heterozygote of Hb Q-Thailand and Hb E in combination with α0-thalassemia and Southeast Asian-type hereditary persistence of fetal hemoglobin (SEA-HPFH). Family study identified that her father was a double heterozygote for Hb Q-Thailand and Hb E, whereas her mother was a heterozygote for SEA-HPFH with α0-thalassemia. Moreover, his brother was a classical Hb QH disease patient. The genotype–phenotype relationship observed in this Chinese family with complex thalassemia syndromes is presented. This work will provide some clinical implications for molecular diagnosis for complex hemoglobinopathies.
Literature
1.
go back to reference Zeng FY, Fucharoen S, Huang SZ, Rodgers GP (1992) Hb Q-Thailand [α74(EF3)Asp → His]: gene organization, molecular structure, and DNA diagnosis. Hemoglobin 16:481–491CrossRefPubMed Zeng FY, Fucharoen S, Huang SZ, Rodgers GP (1992) Hb Q-Thailand [α74(EF3)Asp → His]: gene organization, molecular structure, and DNA diagnosis. Hemoglobin 16:481–491CrossRefPubMed
2.
go back to reference Fucharoen S, Winichagoon P (2000) Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr Opin Hematol 7:106–112CrossRefPubMed Fucharoen S, Winichagoon P (2000) Clinical and hematologic aspects of hemoglobin E beta-thalassemia. Curr Opin Hematol 7:106–112CrossRefPubMed
4.
go back to reference Beris P, Huber P, Miescher PA, Wilson JB, Kutlar A, Chen SS et al (1987) Hb Q-Hb H disease in a Chinese living in Geneva, Switzerland: characterization of the variant and identification of the two alpha-thalassemic chromosomes. Am J Hematol 24:395–400CrossRefPubMed Beris P, Huber P, Miescher PA, Wilson JB, Kutlar A, Chen SS et al (1987) Hb Q-Hb H disease in a Chinese living in Geneva, Switzerland: characterization of the variant and identification of the two alpha-thalassemic chromosomes. Am J Hematol 24:395–400CrossRefPubMed
5.
go back to reference Li D, Liao C, Xie X, Zhong H, Li J (2007) Four cases of Hb Q-H disease found in Southern China. Hemoglobin 31:109–111CrossRefPubMed Li D, Liao C, Xie X, Zhong H, Li J (2007) Four cases of Hb Q-H disease found in Southern China. Hemoglobin 31:109–111CrossRefPubMed
6.
go back to reference Leung KF, Ma ES, Chan AY, Chan LC (2004) Clinical phenotype of haemoglobin Q-H disease. J Clin Pathol 57:81–82CrossRefPubMed Leung KF, Ma ES, Chan AY, Chan LC (2004) Clinical phenotype of haemoglobin Q-H disease. J Clin Pathol 57:81–82CrossRefPubMed
7.
go back to reference Boonsa S, Sanchaisuriya K, Fucharoen G, Wiangnon S, Jetsrisuparb A, Fucharoen S (2004) The diverse molecular basis and hematological features of Hb H and AEBart's diseases in northeast Thailand. Acta Haematol 111:149–154CrossRefPubMed Boonsa S, Sanchaisuriya K, Fucharoen G, Wiangnon S, Jetsrisuparb A, Fucharoen S (2004) The diverse molecular basis and hematological features of Hb H and AEBart's diseases in northeast Thailand. Acta Haematol 111:149–154CrossRefPubMed
8.
go back to reference Fucharoen S, Winichagoon P, Thonglairuam V, Wasi P (1988) EFBart's disease: interaction of the abnormal alpha- and beta globin genes. Eur J Haematol 40:75–78CrossRefPubMed Fucharoen S, Winichagoon P, Thonglairuam V, Wasi P (1988) EFBart's disease: interaction of the abnormal alpha- and beta globin genes. Eur J Haematol 40:75–78CrossRefPubMed
9.
go back to reference Fucharoen G, Trithipsombat J, Sirithawee S, Yamsri S, Changtrakul Y, Sanchaisuriya K, Fucharoen S (2006) Molecular and hematological profiles of hemoglobin EE disease with different forms of α-thalassemia. Ann Hematol 85:450–454CrossRefPubMed Fucharoen G, Trithipsombat J, Sirithawee S, Yamsri S, Changtrakul Y, Sanchaisuriya K, Fucharoen S (2006) Molecular and hematological profiles of hemoglobin EE disease with different forms of α-thalassemia. Ann Hematol 85:450–454CrossRefPubMed
10.
go back to reference Lin CK, Gau JP, Hsu HC, Jiang ML (1990) Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol 12:409–415PubMedCrossRef Lin CK, Gau JP, Hsu HC, Jiang ML (1990) Efficacy of a modified improved technique for detecting red cell haemoglobin H inclusions. Clin Lab Haematol 12:409–415PubMedCrossRef
11.
go back to reference Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A (1991) An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods 34:105–112CrossRefPubMed Loparev VN, Cartas MA, Monken CE, Velpandi A, Srinivasan A (1991) An efficient and simple method of DNA extraction from whole blood and cell lines to identify infectious agents. J Virol Methods 34:105–112CrossRefPubMed
12.
go back to reference Fucharoen G, Fucharoen S (1994) Rapid and simultaneous nonradioactive method for detecting α0-thalassemia (SEA-type) and Hb Constant Spring genes. Eur J Haematol 53:186–187CrossRefPubMed Fucharoen G, Fucharoen S (1994) Rapid and simultaneous nonradioactive method for detecting α0-thalassemia (SEA-type) and Hb Constant Spring genes. Eur J Haematol 53:186–187CrossRefPubMed
13.
go back to reference Xu XM, Li ZQ, Liu ZY, Zhong XL, Zhao YZ, Mo QH (2000) Molecular characterization and PCR detection of a deletional HPFH: application to rapid prenatal diagnosis for compound heterozygotes of this defect with beta-thalassemia in a Chinese family. Am J Hematol 65:183–188CrossRefPubMed Xu XM, Li ZQ, Liu ZY, Zhong XL, Zhao YZ, Mo QH (2000) Molecular characterization and PCR detection of a deletional HPFH: application to rapid prenatal diagnosis for compound heterozygotes of this defect with beta-thalassemia in a Chinese family. Am J Hematol 65:183–188CrossRefPubMed
14.
go back to reference Xu XM et al (1996) Antenatal screening and fetal diagnosis of â-thalassemia in a Chinese population: prevalence of the â-thalassemia trait in the Guangzhou area of China. Hum Genet 98:199–202CrossRefPubMed Xu XM et al (1996) Antenatal screening and fetal diagnosis of â-thalassemia in a Chinese population: prevalence of the â-thalassemia trait in the Guangzhou area of China. Hum Genet 98:199–202CrossRefPubMed
15.
go back to reference Sanchaisuriya K, Chunpanich S, Fucharoen S, Fucharoen G, Sanchaisuriya P, Changtrakun Y (2005) Association of Hb Q with homozygous Hb E and heterozygous Hb Constant Spring in pregnancy. Eur J Haematol 74:221–227CrossRefPubMed Sanchaisuriya K, Chunpanich S, Fucharoen S, Fucharoen G, Sanchaisuriya P, Changtrakun Y (2005) Association of Hb Q with homozygous Hb E and heterozygous Hb Constant Spring in pregnancy. Eur J Haematol 74:221–227CrossRefPubMed
16.
go back to reference Tan J, Tay JS, Wong YC, Kham SK, Bte Abd Aziz N, Teo SH (1995) Molecular analysis of Hb Q-H disease and Hb Q-Hb E in a Singaporean family. Southeast Asian J Trop Med Public Health 26(Suppl 1):252–256PubMed Tan J, Tay JS, Wong YC, Kham SK, Bte Abd Aziz N, Teo SH (1995) Molecular analysis of Hb Q-H disease and Hb Q-Hb E in a Singaporean family. Southeast Asian J Trop Med Public Health 26(Suppl 1):252–256PubMed
17.
go back to reference Dimovski AJ, Divoky V, Adekile AD, Baysal E, Wilson JB, Prior JF (1994) A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3′HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin? Blood 83:822–827PubMed Dimovski AJ, Divoky V, Adekile AD, Baysal E, Wilson JB, Prior JF (1994) A novel deletion of approximately 27 kb including the beta-globin gene and the locus control region 3′HS-1 regulatory sequence: beta zero-thalassemia or hereditary persistence of fetal hemoglobin? Blood 83:822–827PubMed
18.
go back to reference Sanchaisuriya K, Fucharoen G, Sae-ung N, Jetsrisuparb A, Fucharoen S (2003) Molecular and hematologic features of hemoglobin E heterozygotes with different forms of alpha-thalassemia in Thailand. Ann Hematol 82:612–616CrossRefPubMed Sanchaisuriya K, Fucharoen G, Sae-ung N, Jetsrisuparb A, Fucharoen S (2003) Molecular and hematologic features of hemoglobin E heterozygotes with different forms of alpha-thalassemia in Thailand. Ann Hematol 82:612–616CrossRefPubMed
19.
go back to reference Orkin SH, Kazazian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP (1982) Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 300:768–769CrossRefPubMed Orkin SH, Kazazian HH Jr, Antonarakis SE, Ostrer H, Goff SC, Sexton JP (1982) Abnormal RNA processing due to the exon mutation of beta E-globin gene. Nature 300:768–769CrossRefPubMed
20.
go back to reference Bianco I, Lerone M, Foglietta E, Deidda G, Cappabianca MP, Morlupi L (1997) Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication. Haematologica 82:513–525PubMed Bianco I, Lerone M, Foglietta E, Deidda G, Cappabianca MP, Morlupi L (1997) Phenotypes of individuals with a beta thal classical allele associated either with a beta thal silent allele or with alpha globin gene triplication. Haematologica 82:513–525PubMed
21.
go back to reference Changsri K, Akkarapathumwong V, Jamsai D, Winichagoon P, Fucharoen S (2006) Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin. Int J Hematol 83:229–237CrossRefPubMed Changsri K, Akkarapathumwong V, Jamsai D, Winichagoon P, Fucharoen S (2006) Molecular mechanism of high hemoglobin F production in Southeast Asian-type hereditary persistence of fetal hemoglobin. Int J Hematol 83:229–237CrossRefPubMed
22.
go back to reference Chen FE, Ooi C, Ha SY, Cheung BM, Todd D, Liang R (2000) Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 343:544–550CrossRefPubMed Chen FE, Ooi C, Ha SY, Cheung BM, Todd D, Liang R (2000) Genetic and clinical features of hemoglobin H disease in Chinese patients. N Engl J Med 343:544–550CrossRefPubMed
23.
go back to reference Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and haemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747CrossRefPubMed Joutovsky A, Hadzi-Nesic J, Nardi MA (2004) HPLC retention time as a diagnostic tool for hemoglobin variants and haemoglobinopathies: a study of 60000 samples in a clinical diagnostic laboratory. Clin Chem 50:1736–1747CrossRefPubMed
Metadata
Title
Complex interaction of Hb Q-Thailand and Hb E with α0-thalassemia and hereditary persistence of fetal hemoglobin in a Chinese family
Authors
Weidong Zheng
Yanhui Liu
Dong Chen
Kabin Rong
Yanfen Ge
Caiping Gong
Heping Chen
Publication date
01-09-2010
Publisher
Springer-Verlag
Published in
Annals of Hematology / Issue 9/2010
Print ISSN: 0939-5555
Electronic ISSN: 1432-0584
DOI
https://doi.org/10.1007/s00277-010-0935-z

Other articles of this Issue 9/2010

Annals of Hematology 9/2010 Go to the issue

Letter to the Editor

Hyperlipidemic myeloma

Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.